Davari Ali, Piroozkhah Moein, Iranpour Abedin, Nejadghaderi Seyed Aria
Animal Core Facility, Reproductive Biomedicine Research Center, Royan Institute for Animal Biotechnology, ACECR, Tehran, Iran.
School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Sci Rep. 2025 Jul 1;15(1):21950. doi: 10.1038/s41598-025-04196-w.
This research aimed to assess the trends in the burden of age-related macular degeneration (AMD) in the Eastern Mediterranean Region (EMR) by age, sex, socio-demographic index (SDI), and location. We extracted data on the prevalence and years lived with disability (YLDs) of AMD from the Global Burden of Disease (GBD) study 2021. The data included all 22 countries in the EMR from 1990 to 2021. Estimates were presented as counts, age-standardized rates per 100,000, and their corresponding 95% uncertainty intervals (UIs). In 2021, the EMR had an age-standardized point prevalence for AMD of 196.8 (95% UI: 161.5 to 240.2) and a YLD rate of 14.9 (10.3 to 20.5) per 100,000 individuals, which represents a decline of 8.1% (from - 11.1% to -5.0%) and 13.3% (from - 16.7% to -9.7%), respectively, when compared to the data from 1990. In 2021, Iran exhibited the highest age-standardized YLD rate at 25.0 (17.2 to 34.9), while Somalia recorded the lowest rate at 8.0 (5.2 to 11.8). Notably, all countries within the EMR demonstrated a reduction in their age-standardized YLD rates from 1990 to 2021, except Yemen. We found an M-shaped relationship between AMD burden and the SDI during 1990-2021. The burden initially increased until reaching an SDI of 0.3, followed by a decline to 0.4, then rose again, peaking at an SDI of 0.6, before showing a final descending trend at SDI values. Despite a reduction in the burden of AMD over the past thirty years, its prevalence continues to be remarkable. Our findings revealed that women experienced a greater burden of AMD than men in the EMR. Additionally, this study highlighted a reduction in age-standardized prevalence and YLD rates. These insights can serve as a foundational basis for developing policies aimed at preventing and treating AMD.
本研究旨在按年龄、性别、社会人口指数(SDI)和地理位置评估东地中海区域(EMR)年龄相关性黄斑变性(AMD)的负担趋势。我们从《2021年全球疾病负担(GBD)研究》中提取了AMD的患病率和残疾生存年数(YLDs)数据。数据涵盖了1990年至2021年EMR的所有22个国家。估计数表示为计数、每10万人的年龄标准化率及其相应的95%不确定区间(UIs)。2021年,EMR的AMD年龄标准化点患病率为196.8(95%UI:161.5至240.2),每10万人的YLD率为14.9(10.3至20.5),与1990年的数据相比,分别下降了8.1%(从-11.1%至-5.0%)和13.3%(从-16.7%至-9.7%)。2021年,伊朗的年龄标准化YLD率最高,为25.0(17.2至34.9),而索马里的率最低,为8.0(5.2至11.8)。值得注意的是,1990年至2021年期间,EMR内所有国家的年龄标准化YLD率均有所下降,但也门除外。我们发现1990年至2021年期间AMD负担与SDI之间呈M形关系。负担最初上升,直至SDI达到0.3,随后下降至0.4,然后再次上升,在SDI为0.6时达到峰值,之后在更高的SDI值时呈现最终下降趋势。尽管过去三十年AMD负担有所减轻,但其患病率仍然很高。我们的研究结果显示,在EMR中,女性经历的AMD负担比男性更重。此外,本研究强调了年龄标准化患病率和YLD率的下降。这些见解可为制定预防和治疗AMD的政策提供基础依据。